Offer - Urjas Oil for just ₹ 1 X
Ergagin 0.125 Injection is a prescription drug, available for use as Injection. Post Delivery Bleeding are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Ergagin 0.125 Injection. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Ergagin 0.125 Injection include Headache, Abdominal Pain, Hypertension. Apart from the aforementioned side effects, Ergagin 0.125 Injection can also lead to other problems, which have been listed below. Such side effects of Ergagin 0.125 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Ergagin 0.125 Injection's effect is Unknown during pregnancy and Unknown for lactating mothers. In addition, Ergagin 0.125 Injection's effects on the liver, heart and kidney are discussed below in the Ergagin 0.125 Injection related warnings section.
Ergagin 0.125 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. High Blood Pressure are examples of such conditions. Other conditions have been mentioned below in the Ergagin 0.125 Injection contraindications section.
Drug reaction of Ergagin 0.125 Injection with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Ergagin 0.125 Injection is considered safe while driving, and is addictive.
Ergagin 0.125 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Ergagin 0.125 Injection safe for pregnant women?
The effects of Ergagin on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Ergagin 0.125 Injection safe during breastfeeding?
No research work has been carried out till date on effect of Ergagin on breastfeeding women. So it is not known whether taking Ergagin will cause side effects or not.
What is the effect of Ergagin 0.125 Injection on the Kidneys?
Very few cases of side effects of Ergagin on kidney have been reported.
What is the effect of Ergagin 0.125 Injection on the Liver?
Ergagin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Ergagin 0.125 Injection on the Heart?
Effects of Ergagin on heart can be severe. It is not safe to use without doctor's advice.
If you are suffering from any of the following diseases, you should not take Ergagin 0.125 Injection unless your doctor advises you to do so -
Is this Ergagin 0.125 Injection habit forming or addictive?
Ergagin 0.125 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Ergagin 0.125 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Ergagin 0.125 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Ergagin 0.125 Injection cannot treat any kind of mental disorder.
Interaction between Food and Ergagin 0.125 Injection
There isn't any research available on the side effects of taking Ergagin 0.125 Injection with food.
Interaction between Alcohol and Ergagin 0.125 Injection
Due to lack of research, there is no information about the side effects of taking Ergagin 0.125 Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839